| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.21B | +136.4% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | — |
| Gross margin | 32.1% | Net margin 3.1% |
| Revenue Q/Q | -10.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.14B | 67.9% |
| R&D | ¥0.02B | 10.0% |
| SG&A | ¥0.03B | 13.2% |
| Tax & other | ¥0.00B | 0.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
飞凯材料 ・ 天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气 ・ 道氏技术 ・ 正业科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies